sk&f-38393 and hydrogen sulfide

sk&f-38393 has been researched along with hydrogen sulfide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, SZ; Chang, GQ; Hao, JH; Li, HZ; Sun, FQ; Wei, C; Wen, X; Wu, R; Xi, YX; Zaid, A	1

Other Studies

1 other study(ies) available for sk&f-38393 and hydrogen sulfide

Article	Year
SKF38393 prevents high glucose (HG)-induced endothelial dysfunction by inhibiting the effects of HG on cystathionine γ-lyase/hydrogen sulfide activity and via a RhoA/ROCK1 pathway. Frontiers in bioscience (Landmark edition), 2022, 02-11, Volume: 27, Issue:2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cystathionine gamma-Lyase; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; rho-Associated Kinases; rhoA GTP-Binding Protein	2022

Article

Year

SKF38393 prevents high glucose (HG)-induced endothelial dysfunction by inhibiting the effects of HG on cystathionine γ-lyase/hydrogen sulfide activity and via a RhoA/ROCK1 pathway.

Frontiers in bioscience (Landmark edition), 2022, 02-11, Volume: 27, Issue:2

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cystathionine gamma-Lyase; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; rho-Associated Kinases; rhoA GTP-Binding Protein

2022